Remove keyword infusion
article thumbnail

Grand Rounds January 12, 2024: Design and Implementation of a Weighted Lottery to Equitably Allocate Scarce Covid-19 Resources (Erin K. McCreary, PharmD, BCIDP)

Rethinking Clinical Trials

UPMC built upon the success of the Remdesivir lottery and in December 2020, UPMC began infusing monoclonal antibodies across 45 UPMC locations. The first monoclonal antibody (mABs) treatment for treatment of COVID-19 was approved in November 2020. Clinicians wrote a consult for mABs and the pharmacy delivered whichever mAB that was available.